This information is intended for Canadian residents.

COVIFENZ®

COVID-19 Vaccine (plant-based virus-like particles [VLP], recombinant, adjuvanted)

Click here to see the COVIFENZ product monograph. This product monograph is intended for use by healthcare professionals in Canada.

Click here to see the COVIFENZ patient medication information.

Canadian regulations limit the information we are permitted to give on prescription drugs on digital platforms.

Please consult a healthcare professional for more detailed information and to discuss the appropriateness of a particular vaccine.

For medical information or to report a side effect or product complaint, please call Medicago at 1-800-622-6067 or email medinfo.can@medicago.com and to Health Canada as well through the Canada Vigilance Program at 1-866-234-2345.

If you encounter technical difficulties in viewing our product information, please contact us.